Home › Products › Oncology › Tegoyes 15mg Capsule

Tegoyes 15mg Capsule

Salt Composition: TEGAFUR,GIMERACIL,OTERACIL

₹2147.00₹2781.56

Inclusive of all taxes

Tegoyes 15mg Capsule

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Tegoyes 15mg Capsule is a combination chemotherapy medication containing the active constituents Tegafur, Gimeracil, and Oteracil. The combination chemotherapy treatment known as S-1 is used to treat various types of cancer, including gastric, colorectal, breast, and pancreatic cancer. This capsule is not recommended for adolescents and children under 18 years of age and may be given alone or in combination with other anticancer drugs. It is important to inform your doctor if you have severe blood disorders, kidney disorders, viral infections, or if you have DPD (enzyme dihydropyrimidine dehydrogenase) deficiency. Tegoyes 15mg Capsule contains lactose. If you have an intolerance to sugars, you should inform your doctor. Use effective contraceptive measures during therapy and for at least 6 months after the last dose.

Uses

Tegoyes 15 mg capsule uses are : Gastric cancer Colorectal cancer Breast cancer Pancreatic cancer

How it works

Tegoyes 15mg Capsule inhibits the growth and division of cancer cells, improves the effectiveness of the treatment, and reduces the risk of side effects, thereby providing therapeutic benefits to cancer patients.

How to Use

Tegoyes 15mg Capsules are typically taken orally, with or without food. The Capsule should be swallowed whole, not crushed, chewed, or broken. The recommended Tegoyes 15 mg dosage can vary depending on the type of cancer being treated and other factors such as your overall health and response to treatment. Do not take a double dose to make up for a missed dose.

Side Effects

Like all medications, Tegoyes capsule side effects may occur , although not everyone will experience them. Serious: Infection (fever, chills, sore throat, cough, flu-like symptoms) Bleeding or bruising (nosebleeds, bleeding gums) Shortness of breath or difficulty breathing Chest pain Irregular heartbeat Seizures Allergic reaction (swelling of the face, tongue, or throat; difficulty breathing) Liver problems (yellowing of the skin or eyes, dark urine, abdominal pain) Kidney problems (changes in urine output, swelling of the hands or feet) Common: Nausea Vomiting Diarrhea Loss of appetite Fatigue Mouth sores Skin rash Changes in taste Abdominal pain Constipation Headache

References

  1. Nordic Group BV, European Medicines Agency, [Revised on 19/11/2020], [Accessed on 06/05/2023], https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf
  2. Masao Kobayakawa, Yasushi Kojima; Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies; OncoTargets and Therapy; [Published on 2011]; [Accessed on 06/05/2023]; https://pubmed.ncbi.nlm.nih.gov/22162925/
  3. Mahlberg R et al; New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin; Chemotherapy; [Published on 2017]; [Accessed on 06/05/2023]; https://www.karger.com/Article/Abstract/443984

Safety Advice

Pregnancy: unsafe Tegoyes 15mg Capsule is unsafe during pregnancy. It can harm the developing fetus, so pregnancy should be avoided while taking this Tegoyes capsule pregnancy safety.

Lungs: Consult your doctor If you have a lung disease or lung cancer and are considering treatment with Tegoyes 15mg Capsule, it is important to discuss this medication's potential benefits and risks with your healthcare provider.

Breastfeeding: Consult your doctor It is unknown whether Tegoyes 15mg Capsules are excreted into human breast milk, so breastfeeding women should consult a doctor before taking it.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS